-
August 21, 2024
Notice of Address ChangeREAD MORE
-
August 07, 2024
Xeureka begins AI drug discovery support for FunPep research on antibody-inducing peptidesREAD MORE
-
May 02, 2024
【Case study】Target AnalysisREAD MORE
-
February 01, 2024
Mitsui & Co. Subsidiary, Xeureka, Launches Tokyo-1 Project Propelling AI-Driven Drug DiscoveryREAD MORE
-
May 31, 2023
Xeureka Accelerates AI Drug Discovery with Cutting-edge Supercomputer Powered by NVIDIA, Launches Tokyo-1 Project for Leading Pharmaceutical Companies in JapanREAD MORE
-
November 11, 2021
Establishment of AI-driven Drug Discovery CompanyREAD MORE